The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

Europe Next Generation Sequencing Market Overview

The European next-generation sequencing (NGS) market continues to grow, primarily driven by technological advancements and the development of genomics. However, this growth is being impacted by a shortage of skilled professionals and the high risks associated with genetic data privacy in the region. Recent advancements in molecular biology have enhanced sequencing procedures, leading many industry players to introduce innovative NGS technologies. This has contributed to the rise of the New Bioeconomy. For example, in 2018, Roche launched three new AVENIO Tumor Tissue Analysis Kits, and the market continues to be shaped by systems like the Illumina HiSeq 2000 and Oxford Nanopore’s PromethION.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00005459

Europe Next Generation Sequencing Market Strategies

Strategic insights for the European NGS market provide data-driven analysis of the industry landscape, including trends, key players, and regional nuances. These insights offer actionable recommendations that enable businesses to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. By leveraging data analytics, these insights help stakeholders anticipate market shifts and position themselves for long-term success. A future-oriented perspective is essential for making informed decisions. Ultimately, effective strategic insights empower businesses to drive profitability and achieve their business objectives in this dynamic and evolving market.

Europe Next Generation Sequencing Market Insights

The geographic scope of the European next-generation sequencing market refers to the specific areas where a business operates and competes. Understanding local distinctions, such as diverse consumer preferences, varying economic conditions, and different regulatory environments, is crucial for tailoring strategies to specific markets. By identifying underserved areas or adapting their offerings to meet local demands, businesses can expand their reach. This clear market focus allows for more effective resource allocation and targeted marketing campaigns. It also facilitates better positioning against local competitors, ultimately driving growth in those targeted areas.

EUROPE NEXT GENERATION SEQUENCING - MARKET SEGMENTATION

By Product

• Consumables
• Services
• Platforms

By Technology

• Genome Sequencing
• Exome Sequencing
• Resequencing & Targeted Sequencing
• Other

By Application

• Diagnostics
• Drug Discovery
• Precision Medicine
• Others

By End User

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Others

By Geography

• Europe
• UK
• Germany
• France

Company Profiles

• Illumina, Inc.
• Thermo Fisher
• Qiagen N.V.,
• Beijing Genomics Institute
• PerkinElmer, Inc.
• F.Hoffman-La Roche Ltd.
• Agilent Technologies
• Eurofins Scientific
• Oxford Nanopore Technologies Ltd.
• Macrogen Inc.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications